|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3700 SEK | -2.63% |
|
-16.29% | -25.70% |
| 28/05 | Qlucore AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2026 | CI |
| 20/04 | Qlucore Launches AI-powered Software Test for Bladder Cancer Research | MT |
| Fiscal Period: April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | -10.08 | -8.54 | -8.81 | -10.55 | -16.03 | ||
Return on Total Capital | -11.54 | -9.14 | -9.48 | -11.59 | -17.96 | ||
Return On Equity % | -23.71 | -15.85 | -15.53 | -18.04 | -29.85 | ||
Return on Common Equity | -23.71 | -15.85 | -15.53 | -18.04 | -29.85 | ||
Margin Analysis | |||||||
Gross Profit Margin % | 26.25 | 24.12 | 18.45 | 20.16 | -52.9 | ||
SG&A Margin | 44.9 | 73.19 | 72.69 | 60.89 | 88.67 | ||
EBITDA Margin % | -32.36 | -49.84 | -50.89 | -44.97 | -110.21 | ||
EBITA Margin % | -33.04 | -51.07 | -51.84 | -45.84 | -111.31 | ||
EBIT Margin % | -33.04 | -51.07 | -51.84 | -45.84 | -111.31 | ||
Income From Continuing Operations Margin % | -35.84 | -51.84 | -50.67 | -42.73 | -111.42 | ||
Net Income Margin % | -35.84 | -51.84 | -50.67 | -42.73 | -111.42 | ||
Net Avail. For Common Margin % | -35.84 | -51.84 | -50.67 | -42.73 | -111.42 | ||
Normalized Net Income Margin | -22.1 | -32.31 | -31.6 | -26.66 | -69.56 | ||
Levered Free Cash Flow Margin | -16.49 | -51.35 | -69.67 | -95.23 | -79.4 | ||
Unlevered Free Cash Flow Margin | -15.05 | -50.96 | -69.08 | -94.63 | -77.89 | ||
Asset Turnover | |||||||
Asset Turnover | 0.49 | 0.27 | 0.27 | 0.37 | 0.23 | ||
Fixed Assets Turnover | 59.3 | 54.94 | 60.25 | 86.45 | 70.88 | ||
Receivables Turnover (Average Receivables) | 4.62 | 8.58 | 13.64 | 11.39 | 5.19 | ||
Short Term Liquidity | |||||||
Current Ratio | 4.24 | 14.78 | 6.45 | 4.05 | 1.22 | ||
Quick Ratio | 4.18 | 14.69 | 6.4 | 3.77 | 0.82 | ||
Operating Cash Flow to Current Liabilities | -0.15 | -0.99 | -0.7 | -1.9 | -1.4 | ||
Days Sales Outstanding (Average Receivables) | 78.93 | 42.53 | 26.75 | 32.13 | 70.39 | ||
Average Days Payable Outstanding | 20.76 | 28.34 | 42.19 | 40.69 | 16.27 | ||
Long Term Solvency | |||||||
Total Debt/Equity | 12.68 | 4.82 | 4.71 | 4.02 | 3.42 | ||
Total Debt / Total Capital | 11.25 | 4.6 | 4.49 | 3.87 | 3.31 | ||
LT Debt/Equity | 6.18 | 4.03 | 3.36 | 2.53 | 2.39 | ||
Long-Term Debt / Total Capital | 5.49 | 3.85 | 3.21 | 2.43 | 2.32 | ||
Total Liabilities / Total Assets | 20.93 | 9.3 | 13.38 | 12.11 | 16.42 | ||
EBIT / Interest Expense | -14.3 | -82.08 | -54.9 | -47.65 | -45.89 | ||
EBITDA / Interest Expense | -14.01 | -80.09 | -53.89 | -46.75 | -45.44 | ||
(EBITDA - Capex) / Interest Expense | -14.19 | -84.16 | -54.68 | -47.3 | -45.44 | ||
Total Debt / EBITDA | -0.85 | -0.48 | -0.28 | -0.19 | -0.1 | ||
Net Debt / EBITDA | 4.21 | 8.26 | 4.08 | 1.54 | 0.16 | ||
Total Debt / (EBITDA - Capex) | -0.84 | -0.45 | -0.27 | -0.19 | -0.1 | ||
Net Debt / (EBITDA - Capex) | 4.15 | 7.86 | 4.02 | 1.52 | 0.16 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | -15.98 | 33.6 | 39.79 | 16.69 | -49.78 | ||
Gross Profit, 1 Yr. Growth % | -48.98 | 22.78 | 6.93 | 27.49 | -231.78 | ||
EBITDA, 1 Yr. Growth % | -454.59 | 105.74 | 42.74 | 3.12 | 23.07 | ||
EBITA, 1 Yr. Growth % | -492.66 | 106.52 | 41.88 | 3.18 | 21.95 | ||
EBIT, 1 Yr. Growth % | -492.66 | 106.52 | 41.88 | 3.18 | 21.95 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | -592.25 | 93.26 | 36.64 | -1.6 | 30.95 | ||
Net Income, 1 Yr. Growth % | -592.25 | 93.26 | 36.64 | -1.6 | 30.95 | ||
Normalized Net Income, 1 Yr. Growth % | -567.71 | 95.36 | 36.7 | -1.55 | 31.03 | ||
Diluted EPS Before Extra, 1 Yr. Growth % | - | 26.31 | 36.64 | -1.6 | 30.95 | ||
Accounts Receivable, 1 Yr. Growth % | -36.31 | -15 | -8.59 | 92.64 | -32.44 | ||
Net Property, Plant and Equip., 1 Yr. Growth % | -14.38 | 112.6 | -12.57 | -25.67 | -56.35 | ||
Total Assets, 1 Yr. Growth % | 102.89 | 163.61 | -10.28 | -17.7 | -22.28 | ||
Tangible Book Value, 1 Yr. Growth % | 1.47K | 312.46 | -34.3 | -57.35 | -96.02 | ||
Common Equity, 1 Yr. Growth % | 154.85 | 202.38 | -14.32 | -16.49 | -26.1 | ||
Cash From Operations, 1 Yr. Growth % | -167.46 | 529.02 | 18.26 | 110.57 | -16.49 | ||
Capital Expenditures, 1 Yr. Growth % | -45.74 | 712.86 | -58.88 | -17.95 | - | ||
Levered Free Cash Flow, 1 Yr. Growth % | -33.88 | 316.09 | 89.66 | 59.49 | -58.13 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | -38.35 | 352.57 | 89.49 | 59.84 | -58.67 | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % | 6.35 | 5.94 | 36.66 | 27.72 | -23.45 | ||
Gross Profit, 2 Yr. CAGR % | -9.77 | -20.85 | 14.58 | 16.76 | 29.61 | ||
EBITDA, 2 Yr. CAGR % | 112.88 | 170.1 | 71.37 | 21.32 | 12.65 | ||
EBITA, 2 Yr. CAGR % | 231.6 | 184.77 | 71.18 | 20.99 | 12.17 | ||
EBIT, 2 Yr. CAGR % | 231.6 | 184.77 | 71.18 | 20.99 | 12.17 | ||
Earnings From Cont. Operations, 2 Yr. CAGR % | 208.62 | 208.43 | 62.5 | 15.95 | 13.52 | ||
Net Income, 2 Yr. CAGR % | 208.62 | 208.43 | 62.5 | 15.95 | 13.52 | ||
Normalized Net Income, 2 Yr. CAGR % | 206.55 | 202.28 | 63.42 | 16.01 | 13.57 | ||
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | 31.37 | 15.95 | 13.52 | ||
Accounts Receivable, 2 Yr. CAGR % | 128.98 | -26.42 | -11.85 | 32.7 | 14.09 | ||
Net Property, Plant and Equip., 2 Yr. CAGR % | -5.66 | 34.92 | 36.34 | -19.38 | -43.04 | ||
Total Assets, 2 Yr. CAGR % | 62.21 | 131.27 | 53.79 | -14.07 | -20.02 | ||
Tangible Book Value, 2 Yr. CAGR % | 204.95 | 703.92 | 64.61 | -47.06 | -86.97 | ||
Common Equity, 2 Yr. CAGR % | 106.64 | 177.6 | 60.96 | -15.41 | -21.44 | ||
Cash From Operations, 2 Yr. CAGR % | - | 106.18 | 172.75 | 57.81 | 32.61 | ||
Capital Expenditures, 2 Yr. CAGR % | - | 110.02 | 82.83 | -41.91 | - | ||
Levered Free Cash Flow, 2 Yr. CAGR % | - | 65.84 | 180.92 | 73.93 | -18.28 | ||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | 67 | 192.85 | 74.04 | -18.72 | ||
Compound Annual Growth Rate Over Three Years | |||||||
Total Revenues, 3 Yr. CAGR % | - | 14.75 | 16.2 | 29.65 | -6.43 | ||
Gross Profit, 3 Yr. CAGR % | - | -0.01 | -12.5 | 18.73 | 21.56 | ||
EBITDA, 3 Yr. CAGR % | - | 110.48 | 118.37 | 44.68 | 21.9 | ||
EBITA, 3 Yr. CAGR % | - | 183.18 | 125.76 | 44.6 | 21.31 | ||
EBIT, 3 Yr. CAGR % | - | 183.18 | 125.76 | 44.6 | 21.31 | ||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | 164.04 | 135.12 | 37.48 | 20.75 | ||
Net Income, 3 Yr. CAGR % | - | 164.04 | 135.12 | 37.48 | 20.75 | ||
Normalized Net Income, 3 Yr. CAGR % | - | 163.8 | 132.02 | 38.02 | 20.81 | ||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | 19.31 | 20.75 | ||
Accounts Receivable, 3 Yr. CAGR % | - | 64.57 | -20.9 | 14.39 | 5.96 | ||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | 23.68 | 16.75 | 11.38 | -34.29 | ||
Total Assets, 3 Yr. CAGR % | - | 90.71 | 68.67 | 24.86 | -16.9 | ||
Tangible Book Value, 3 Yr. CAGR % | - | 237.24 | 248.87 | 4.95 | -77.65 | ||
Common Equity, 3 Yr. CAGR % | - | 134.6 | 87.61 | 29.34 | -19.13 | ||
Cash From Operations, 3 Yr. CAGR % | - | - | 71.31 | 150.21 | 27.64 | ||
Capital Expenditures, 3 Yr. CAGR % | - | - | 21.96 | 39.98 | - | ||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | 73.43 | 132.62 | 8.2 | ||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | 74.19 | 139.33 | 7.78 | ||
Compound Annual Growth Rate Over Five Years | |||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | 19.77 | -1.67 | ||
Gross Profit, 5 Yr. CAGR % | - | - | - | 6.38 | 2.39 | ||
EBITDA, 5 Yr. CAGR % | - | - | - | 68.85 | 67.58 | ||
EBITA, 5 Yr. CAGR % | - | - | - | 101.53 | 70.66 | ||
EBIT, 5 Yr. CAGR % | - | - | - | 101.53 | 70.66 | ||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | 89.98 | 75.71 | ||
Net Income, 5 Yr. CAGR % | - | - | - | 89.98 | 75.71 | ||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | 89.92 | 74.35 | ||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | 50.99 | -8.42 | ||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 4.22 | -12.38 | ||
Total Assets, 5 Yr. CAGR % | - | - | - | 38.64 | 25.14 | ||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | 60.79 | -6.33 | ||
Common Equity, 5 Yr. CAGR % | - | - | - | 56 | 32.44 | ||
Cash From Operations, 5 Yr. CAGR % | - | - | - | - | 54.63 | ||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 28.35 | ||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 28.41 |
- Stock Market
- Stocks
- QCORE Stock
- Financials Qlucore AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















